BioSpace News Archive

Business

Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Qualigen Therapeutics, Inc. today announces its financial results for the third quarter ended September 30, 2022, and provides an update on its therapeutic pipeline and other corporate developments.

November 15, 2022
·
12 min read
Business

Acerus Reports Third Quarter 2022 Financial Results

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2022.

November 15, 2022
·
13 min read
Drug Development

Alphyn Biologics Completes First Cohort of Phase2a Clinical Trial of Topical Therapeutic for Mild-to-Moderate Atopic Dermatitis

Alphyn Biologics announced today that it has completed the first cohort of its Phase2a clinical trial of AB-101a, a topical therapeutic candidate for mild-to-moderate atopic dermatitis (AD) in adults and children as young as 2 years old.

November 15, 2022
·
2 min read
Pixium Vision announces participation in investor conferences in November and December 2022

Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces that senior management will participate in the following investor conferences in November and December 2022:

November 15, 2022
·
3 min read
Genetown

Nona Biosciences Announces Attendance at PEGS Europe 2022

Nona Biosciences announced that the Company is attending the 14th Protein and Antibody Engineering Summit in Barcelona, Spain, November 14-16, 2022.

November 15, 2022
·
2 min read
Medtronic Launches World’s First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.

Medtronic plc, a global leader in healthcare technology, announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day wear.

November 15, 2022
·
5 min read
Lone Star Bio

RadioMedix and Vect-Horus announce first dosing of Glioblastoma Multiforme and Pancreatic ductal adenocarcinoma patients with 68Ga-RMX-VH

RadioMedix and Vect-Horus are pleased to announce that they have successfully dosed the first patients in an exploratory Investigational New Drug (eIND) application to evaluate 68Ga-RMX-VH for the diagnostic of Glioblastoma Multiforme (GBM) and Pancreatic ductal adenocarcinoma (PDAC).

November 15, 2022
·
4 min read
Genetown

Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform

Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, announced the close of its $107 million Series C financing.

November 15, 2022
·
5 min read
Business

ConcertAI Names Ronan Brown as its First Chief Operations Officer

ConcertAI, a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life sciences and healthcare, today announced the appointment of Ronan Brown as its first chief operating officer.

November 15, 2022
·
2 min read
Business

Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities

Ablexis, LLC and AlivaMab Discovery Services, LLC announced an expansion of platforms and capabilities in antibody drug discovery and engineering.

November 15, 2022
·
4 min read